ABL Bio Email Formats

Biotechnology Research • 16 Daewangpangyo-ro 712 beon-gil, Bundang-gu, Korea, Republic of • 51-100 Employees

ABL Bio Email Formats

ABL Bio uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@ablbio.com), used 92% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@ablbio.com	92%
{first initial}.{last name}	j.doe@ablbio.com	8%

Key Contacts at ABL Bio

Jinwon Jung

Senior Director

Yongsun Kwon

Director Of Business Operations

Hailey Jinsun Kwon

Director

Bryan Kang

Director, Strategy & Corporate Development

Jinhyung Ahn

Senior Director

Company overview

Headquarters	16 Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 13488, KR
Phone number	+82234567300
Website	ablbio.com
NAICS	541714
SIC	873
Keywords	Biotechnology, Immuno-Oncology, Antibody, Neurodegeneration, ADC, Bispecific Antibody, Bbb Penetration, 4-1Bb
Founded	2016
Employees	51-100
Socials

About ABL Bio

ABL Bio Inc. (Kosdaq: 298380) is a South Korean biotechnology company dedicated to the development of bispecific antibody therapeutics to improve and save people's lives. With our BsAb platforms ‘Grabody-T,’ ‘Grabody-I’ and ‘Grabody-B,’ we have built a robust pipeline of multiple clinical and pre-clinical stage drug candidates. In the oncology area, we have developed Grabody-T, a modular 4-1BB engaging platform that has demonstrated excellent efficacy and safety. We also created a next-generation antibody drug conjugate program to treat various cancers. In the neurodegenerative disorder space, we have developed Grabody-B platform, which is designed to maximize blood-brain barrier (BBB) penetration. Grabody-B is applicable to various CNS targets across a plethora of neurological disorders, potentially providing a breakthrough to address the high unmet medical needs in neurodegeneration. We continue to actively expand and advance our pipeline through global strategic partnerships. For more information, please visit http://ablbio.com

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Senior

Manager

Employees by Department

ABL Bio has 18 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore ABL Bio's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-10-07	1	$3,000,000

Funding Insights

$3,000,000

Total funding amount

$3,000,000

Most recent funding amount

Number of funding rounds

ABL Bio Tech Stack

Discover the technologies and tools that power ABL Bio's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Sectigo

SSL/TLS certificate authorities

Swiper

JavaScript libraries

lit-element

JavaScript libraries

Ubuntu

Operating systems

Google Maps

Maps

Bootstrap

UI frameworks

Popper

Miscellaneous

Google Analytics

Analytics

Frequently asked questions

ABL Bio is located in 16 Daewangpangyo-ro 712 beon-gil, Bundang-gu, KR.

You can reach ABL Bio at +82234567300.

ABL Bio was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

ABL Bio has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

ABL Bio has raised a total of $3,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at ABL Bio

Jinwon Jung

Senior Director

Yongsun Kwon

Director Of Business Operations

Hailey Jinsun Kwon

Director

Bryan Kang

Director, Strategy & Corporate Development

Jinhyung Ahn